<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230615058492N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-21</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Lemongrass aromatherapy on reducing anxiety</public_title>
      <acronym></acronym>
      <scientific_title>Evaluating the effect of Lemongrass aromatherapy on reducing the anxiety of patients undergoing scaling and root planing</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74902</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: Blinding in this study will not be possible due to the presence of smellable aroma in the intervention group and its absence in the control group; Because the clinical caregivers and participants will distinguish the scent distinctly from distilled water anyway. However, the data analyst is blinded and has no knowledge of the case and control groups, Randomization description: Randomization is done in the form of simple stratified randomization . The strata include age variable in two groups (aged 25-37 and aged 38-50) and gender in two groups, and in total, random allocation is done in 4 separate layers, 10 samples considered in each layer. First, the age and gender are determined and the eligible individual is entered into the study in one of the 4 layers based on the random allocation table. Using PASS 2021 software, we will generate a random sequence using a simple random allocation method. The output of the software in the form of an Excel file includes the sequence from 1 to 40, the strata and unique codes for the research units. After determining the stratum based on age and gender for the eligible individuals, a number from 1 to 10 is considered for each person; and the person is assigned to an intervention group (A or B). The first eligible patient is assigned number 1, the second is assigned number 2, and so on, up to 10 patients in each stratum, and this is repeated for all the 4 strata. 
Allocation concealment: In order to blindly assign the patients randomly, we will ask for the help of a third person who is unaware of the interventions and this table is given to them. When a patient eligible for the study visits, based on the patient's code, the intervention group will be asked from the third person over the phone and the patient will be assigned to one of the groups.</study_design>
      <phase>4</phase>
      <hc_freetext>Condition 1: Anxiety. Condition 2: Perceived pain during treatment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For this group, 3 drops (0.15 ml) of lemongrass essential oil (100% pure, non-edible) from Naringol brand (Tehran, Iran), which is originally a product of Moksha company (New Delhi, India) diluted in 100 ml of distilled water (according to the manufacturer's instructions), is poured onto sterile cotton/gauze and then rubbed around the patient's nostrils. Aromatherapy will continue from the beginning to the end of scaling and root planing treatment (for 25 to 35 minutes). Intervention 2: Control group: For this group, distilled water will be used for moistening the cotton/gas and rubbing around nostrils.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahta Sadat Vaezpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, the beginning of Imam Reza Blvd, Imam Reza Square</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8914881167</zip>
        <telephone>+98 35 3625 5881</telephone>
        <email>vmahtasadat@gmail.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fahimeh Rashidi Maybodi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, the beginning of Imam Reza Blvd, Imam Reza Square</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8914881167</zip>
        <telephone>+98 35 3625 5881</telephone>
        <email>f_rashidi63@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 25 and 50 years
Having periodontitis stage II to IV and grade A or B</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of scaling and root planing
Having systemic conditions such as high blood pressure, diabetes or lung problems
Smoking
History of allergy to certain medicinal plants
Having allergies or problems such as nasal congestion
Loss of sense of smell due to Covid-19, etc
Being diagnosed with sinusitis
Being diagnosed with anxiety disorders
The patient is pregnant
The patient is breastfeeding
The patient is receiving chemotherapy
Taking pain relievers
Taking anti-anxiety medications
Taking medications that affect heart rate and blood pressure, such as diuretics and beta blockers
Taking antiseizure medications
Taking immunosuppressive medications</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.9</hc_code>
      <hc_code>R52</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anxiety disorder, unspecified</hc_keyword>
      <hc_keyword>Pain, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For this group, 3 drops (0.15 ml) of lemongrass essential oil (100% pure, non-edible) from Naringol brand (Tehran, Iran), which is originally a product of Moksha company (New Delhi, India) diluted in 100 ml of distilled water (according to the manufacturer's instructions), is poured onto sterile cotton/gauze and then rubbed around the patient's nostrils. Aromatherapy will continue from the beginning to the end of scaling and root planing treatment (for 25 to 35 minutes).</i_keyword>
      <i_keyword>Control group: For this group, distilled water will be used for moistening the cotton/gas and rubbing around nostrils</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety score. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: Spielberger’s State-Trait Anxiety Inventory–State Scale (containing 20 questions and scoring from 20 to 80).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Systolic blood pressure. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: Digital sphygmomanometer model Ri-champion N from Riester® (measurement unit: millimeters Hg).</sec_outcome>
      <sec_outcome>Diastolic blood pressure. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: Digital sphygmomanometer model Ri-champion N from Riester® (measurement unit: millimeters Hg).</sec_outcome>
      <sec_outcome>Pulse rate. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: P-01 pulse oximeter device.</sec_outcome>
      <sec_outcome>Arterial blood oxygen saturation percentage. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: P-01 pulse oximeter device.</sec_outcome>
      <sec_outcome>Pain grade on Visual Analogue Scale. Timepoint: After scaling for two thirds of the teeth. Method of measurement: Visual Analogue scale.</sec_outcome>
      <sec_outcome>Patient satisfaction. Timepoint: After scaling for two thirds of the teeth. Method of measurement: Graded scale from 1 to 5 (1=dissatisfied/ 5=completely satisfied).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-12-11</approval_date>
        <contact_name>Ethics Committee of Faculty of Dentistry_ Shahid Sadoughi University of Medical Sciences, Yazd</contact_name>
        <contact_address>Faculty of Dentistry, the beginning of Imam Reza Blvd, Imam Reza Square Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
